Current Animal Models of Chemotherapy-Induced Peripheral Polyneuropathy
https://doi.org/10.33647/2074-5982-20-3-61-65
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of antineoplastic chemotherapy. In a large number of patients, this complication is highly persistent to treatment. The present review is focused on current rodent CIPN models using antineoplastic agents of different groups.
About the Authors
V. A. Prikhodko
Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Care of Russia; N.P. Bechtereva Institute of the Human Brain of the Russian Academy of Sciences
Russian Federation
Russian Federation
Veronika A. Prikhodko, Cand. Sci. (Biol.)
197376, Saint Petersburg, Professora Popova Str., 14, lit. A
197376, Saint Petersburg, Akademika Pavlova Str., 12, lit. A
T. M. Matuzok
Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Care of Russia; N.P. Bechtereva Institute of the Human Brain of the Russian Academy of Sciences
Russian Federation
Russian Federation
Tatyana M. Matuzok
197376, Saint Petersburg, Professora Popova Str., 14, lit. A
197376, Saint Petersburg, Akademika Pavlova Str., 12, lit. A
S V. Okovitiy
Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Sergey V. Okovitiy, Dr. Sci. (Med.), Prof.,
197376, Saint Petersburg, Professora Popova Str., 14, lit. A
References
1. Banach M., Juranek J.K., Zygulska A.L. Chemotherapy-induced neuropathies — a growing problem for patients and health care providers. Brain Behav. 2016;7(1):e00558. DOI: 10.1002/brb3.558
2. Boehmerle W., Huehnchen P., Peruzzaro S., Bal-kaya M., Endres M. Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice. Sci. Rep. 2014;4:6370. DOI: 10.1038/srep06370
3. Gadgil S., Ergün M., van den Heuvel S.A., van der Wal S.E., Scheffer G.J., Hooijmans C.R. A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN). PLoS One. 2019;14(8):e0221787. DOI: 10.1371/journal.pone.0221787
4. Grisold W., Cavaletti G., Windebank A.J. Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention. Neuro Oncol. 2012;14(Suppl 4):iv45–iv54. DOI: 10.1093/neuonc/nos203
5. Malacrida A., Meregalli C., Rodriguez-Menendez V., Nicolini G. Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton. Int. J. Mol. Sci. 2019;20(9):2287. DOI: 10.3390/ijms20092287
6. Seretny M., Currie G.L., Sena E.S., Ramnarine S., Grant R., MacLeod M.R., Colvin L.A., Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461– 2470. DOI: 10.1016/j.pain.2014.09.020
Review
For citations:
Prikhodko V.A., Matuzok T.M., Okovitiy S.V. Current Animal Models of Chemotherapy-Induced Peripheral Polyneuropathy. Journal Biomed. 2024;20(3):61-65. (In Russ.) https://doi.org/10.33647/2074-5982-20-3-61-65
Views:
77
Email this article 
